Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Gebhardt
D O
DO
D000287:Administration, Topical; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy*; D003230:Conjunctival Neoplasms / Q000188:drug therapy*; D003316:Corneal Diseases / Q000188:drug therapy*; D017277:Drug Approval; D005134:Eye Neoplasms / Q000188:drug therapy*; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin